Amatica
Advanced Blood Clotting (Coagulation) Test
Advanced Blood Clotting (Coagulation) Test
View our Professional Blood Draw Locations
Couldn't load pickup availability
Micro-clots have been observed in the blood of Long Covid patients, with evidence showing increased risk of blood clotting events after Covid infection. These fibrinogen-amyloid-rich micro clots may contribute to various pathogenic mechanisms and symptoms.
In the one year after Covid infection, health records from the United States showed a 52% increase in stroke, a 66% increase in ischemic heart diseases, and an overall increased risk of thromboembolism events (including Deep Vein Thrombosis, and Pulmonary Embolism) of 139%.
This test evaluates key coagulation markers including Prothrombin Time, APTT, and Fibrinogen, which collectively shed light on how quickly your blood clots and the balance of clotting factors in your system.
Blood clotting disorders can manifest as persistent fatigue, brain fog, or more severe complications such as stroke, ischemic heart disease, or pulmonary embolism. Regular monitoring of blood clotting dynamics can help clinicians and healthcare practitioners identify at risk individuals allowing preventative action to be taken.
![Advanced Blood Clotting (Coagulation) Test](http://amaticahealth.com/cdn/shop/products/product_image_363b85f3-f80d-40ca-b07e-d5e30ee97e2a.jpg?v=1691007342&width=1445)